218 related articles for article (PubMed ID: 15911340)
1. How can the mood stabilizer VPA limit both mania and depression?
Cheng L; Lumb M; Polgár L; Mudge AW
Mol Cell Neurosci; 2005 Jun; 29(2):155-61. PubMed ID: 15911340
[TBL] [Abstract][Full Text] [Related]
2. The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters.
Di Daniel E; Cheng L; Maycox PR; Mudge AW
Mol Cell Neurosci; 2006; 32(1-2):27-36. PubMed ID: 16531065
[TBL] [Abstract][Full Text] [Related]
3. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
Teo R; King J; Dalton E; Ryves J; Williams RS; Harwood AJ
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1110-4. PubMed ID: 19754462
[TBL] [Abstract][Full Text] [Related]
4. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
Watson DG; Watterson JM; Lenox RH
J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
[TBL] [Abstract][Full Text] [Related]
5. Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes.
Stoll AL; Severus WE
Harv Rev Psychiatry; 1996; 4(2):77-89. PubMed ID: 9384977
[TBL] [Abstract][Full Text] [Related]
6. A common mechanism of action for three mood-stabilizing drugs.
Williams RS; Cheng L; Mudge AW; Harwood AJ
Nature; 2002 May; 417(6886):292-5. PubMed ID: 12015604
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of divalproate in all forms of mania and the broader bipolar spectrum: many questions, few answers.
Bowden C
J Affect Disord; 2004 Apr; 79 Suppl 1():S9-14. PubMed ID: 15121342
[TBL] [Abstract][Full Text] [Related]
8. Valproate decreases inositol biosynthesis.
Shaltiel G; Shamir A; Shapiro J; Ding D; Dalton E; Bialer M; Harwood AJ; Belmaker RH; Greenberg ML; Agam G
Biol Psychiatry; 2004 Dec; 56(11):868-74. PubMed ID: 15576064
[TBL] [Abstract][Full Text] [Related]
9. Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited.
Harwood AJ
Mol Psychiatry; 2005 Jan; 10(1):117-26. PubMed ID: 15558078
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the H(+)-myo-inositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling.
Di Daniel E; Kew JN; Maycox PR
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1139-43. PubMed ID: 19754467
[TBL] [Abstract][Full Text] [Related]
11. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior.
Shimshoni JA; Dalton EC; Jenkins A; Eyal S; Ewan K; Williams RS; Pessah N; Yagen B; Harwood AJ; Bialer M
Mol Pharmacol; 2007 Mar; 71(3):884-92. PubMed ID: 17167030
[TBL] [Abstract][Full Text] [Related]
12. Mood stabilizers: protecting the mood...protecting the brain.
Brunello N
J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
[TBL] [Abstract][Full Text] [Related]
13. Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine.
Valvassori SS; Rezin GT; Ferreira CL; Moretti M; Gonçalves CL; Cardoso MR; Streck EL; Kapczinski F; Quevedo J
J Psychiatr Res; 2010 Oct; 44(14):903-9. PubMed ID: 20334877
[TBL] [Abstract][Full Text] [Related]
14. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.
Friedman SD; Dager SR; Parow A; Hirashima F; Demopulos C; Stoll AL; Lyoo IK; Dunner DL; Renshaw PF
Biol Psychiatry; 2004 Sep; 56(5):340-8. PubMed ID: 15336516
[TBL] [Abstract][Full Text] [Related]
15. Search for a common mechanism of mood stabilizers.
Harwood AJ; Agam G
Biochem Pharmacol; 2003 Jul; 66(2):179-89. PubMed ID: 12826261
[TBL] [Abstract][Full Text] [Related]
16. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.
Chen PS; Peng GS; Li G; Yang S; Wu X; Wang CC; Wilson B; Lu RB; Gean PW; Chuang DM; Hong JS
Mol Psychiatry; 2006 Dec; 11(12):1116-25. PubMed ID: 16969367
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.
Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC
Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549
[TBL] [Abstract][Full Text] [Related]
18. Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity.
Di Daniel E; Glover CP; Grot E; Chan MK; Sanderson TH; White JH; Ellis CL; Gallagher KT; Uney J; Thomas J; Maycox PR; Mudge AW
Mol Cell Neurosci; 2009 Jul; 41(3):373-82. PubMed ID: 19332125
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions.
Fukuchi M; Nii T; Ishimaru N; Minamino A; Hara D; Takasaki I; Tabuchi A; Tsuda M
Neurosci Res; 2009 Sep; 65(1):35-43. PubMed ID: 19463867
[TBL] [Abstract][Full Text] [Related]
20. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
Nasrallah HA; Ketter TA; Kalali AH
J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]